Table of Contents
Pharmaceuticals, Volume 13, Issue 3 (March 2020) – 19 articles
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
- You may sign up for e-mail alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Cover Story (view full-size image) Targeted imaging in oncology can provide tumor-type specific non-invasive diagnosis and the precise [...] Read more. Targeted imaging in oncology can provide tumor-type specific non-invasive diagnosis and the precise localization of tumors and metastases that, most importantly, have the potential for pre-therapeutic quantification of receptor status, uptake kinetics, and dosimetry. This technique can enable accurate therapy selection and planning as well as monitoring of the response to therapy, resulting in personalized medicine. For example, reliable whole-body, quantitative assessment of HER2 receptor expression is crucial to identify patients with HER2-positive tumors who can benefit from HER2-targeted treatments. It is as important to avoid unnecessary costs as well as the potential risk of serious adverse effects and time delay related to the treatment of patients with HER2-negative tumors. The number of radiopharmaceuticals contributing to the realization of theranostics/radiotheranostics in the context of personalized medicine is increasing. Vi